¼¼°èÀÇ ¸»ÃÊÇ÷°ü ±â±â ½ÃÀå
Peripheral Vascular Devices
»óǰÄÚµå : 1765150
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 192 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,198,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,594,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¸»ÃÊÇ÷°ü ±â±â ¼¼°è ½ÃÀåÀº 2030³â±îÁö 160¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 127¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¸»ÃÊÇ÷°ü ±â±â ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 4.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 160¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Ç÷°ü¼ºÇü¼ú ½ºÅÙÆ®´Â CAGR 4.6%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 91¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ç÷°ü¼ºÇü¼ú dz¼± ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 3.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 34¾ï ´Þ·¯, Áß±¹Àº CAGR 3.6%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ ¸»ÃÊÇ÷°ü ±â±â ½ÃÀåÀº 2024³â¿¡ 34¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 25¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 3.6%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.7%¿Í 3.3%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.8%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¸»ÃÊÇ÷°ü ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¸»ÃÊÇ÷°ü ±â±â°¡ Çö´ë ÀÇ·á¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀϱî?

¸»ÃÊÇ÷°ü ±â±â´Â ½ÉÀåÀ̳ª ³ú¸¦ Á¦¿ÜÇÑ µ¿¸Æ, Á¤¸Æ, ¸²ÇÁ°ü µî ¸»ÃÊÇ÷°ü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁúȯÀÇ Áø´Ü°ú Ä¡·á¿¡ ÇʼöÀûÀÎ µµ±¸ÀÔ´Ï´Ù. ½ºÅÙÆ®, Ä«Å×ÅÍ, dz¼±, ÇÊÅÍ µîÀ» Æ÷ÇÔÇÑ À̵é ÀåÄ¡´Â ¸»Ãʵ¿¸ÆÁúȯ(PAD), ½ÉºÎÁ¤¸ÆÇ÷ÀüÁõ(DVT), ¸¸¼ºÁ¤¸ÆºÎÀü(CVI) µîÀÇ ÁúȯÀ» °ü¸®Çϱâ À§ÇØ »ç¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ ±â±âÀÇ Á߿伺Àº ÀûÀýÇÑ Ç÷·ù¸¦ ȸº¹Çϰí, ÇÕº´Áõ À§ÇèÀ» ÁÙÀ̰í, ȯÀÚÀÇ °á°ú¸¦ °³¼±ÇÏ´Â ´É·Â¿¡ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Ç÷°ü ¼ºÇü¼ú¿ë dz¼±À̳ª ½ºÅÙÆ®´Â Á¼¾ÆÁö°Å³ª ¸·Èù µ¿¸ÆÀ» ¿­¾î Ç÷¾× ¼øÈ¯À» ÃËÁøÇϰí Á¶Á÷ ¼Õ»óÀ» ¹æÁöÇϱâ À§ÇØ È°¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ ±â±¸¸¦ ÀÌ¿ëÇÑ ÃÖ¼Òħ½ÀÀû ½Ã¼úÀÇ °³¹ßÀº Ç÷°ü ¼ö¼ú¿¡ Çõ¸íÀ» °¡Á®¿ÔÀ¸¸ç, ȸº¹ ½Ã°£À» ´ÜÃàÇϰí ȯÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃÄ×½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¾î¶»°Ô ¸»ÃÊ Ç÷°ü ±â±â¸¦ Çü¼ºÇϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº ¸»ÃÊÇ÷°ü ±â±âÀÇ ±â´É°ú È¿´ÉÀ» Å©°Ô Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀçÇùÂøÀ» ¹æÁöÇϱâ À§ÇØ ¾à¹°À» ¹æÃâÇÏ´Â ¾à¹° ¿ëÃ⼺ ½ºÅÙÆ®, Ç÷·ù¸¦ ȸº¹½ÃŲ ÈÄ ¼­¼­È÷ ¿ëÇØµÇ´Â »ýü Èí¼ö¼º ½ºÅÙÆ® µîÀÇ Çõ½ÅÀûÀÎ Ä¡·á¹ýÀº Ç÷°ü Ä¡·áÀÇ Áß¿äÇÑ µ¹ÆÄ±¸ÀÔ´Ï´Ù. ¶ÇÇÑ, Ç÷°ü ³» ÃÊÀ½ÆÄ(IVUS), ±¤°£¼·´ÜÃþÃÔ¿µ(OCT) µî ¿µ»óÁø´Ü ±â¼úÀÇ ¹ßÀüÀ¸·Î ½ºÅÙÆ® »ðÀÔÀÇ Á¤È®µµ¿Í Ç÷°ü »óÅ Æò°¡°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. Çü»ó±â¾ïÇÕ±Ý ¹× »ýüÀûÇÕ¼º Æú¸®¸Ó¿Í °°Àº ÷´Ü ¼ÒÀçÀÇ ÅëÇÕÀº ÀÌ·¯ÇÑ ÀåÄ¡ÀÇ ³»±¸¼º°ú ¼º´ÉÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾à¹° Àü´Þ ¹× ±â°èÀû ÁöÁö¿Í °°Àº ¿©·¯ ±â´ÉÀ» °áÇÕÇÑ ÇÏÀ̺긮µå µð¹ÙÀ̽ºÀÇ °³¹ß·Î ÀÓ»óÀǰ¡ »ç¿ëÇÒ ¼ö ÀÖ´Â Ä¡·á ¿É¼ÇÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº Ä¡·á¸¦ º¸´Ù ¾ÈÀüÇϰí, È¿°úÀûÀ̸ç, ´ú ħ½ÀÀûÀÎ Ä¡·á·Î ¸¸µé¾îÁÖ°í ÀÖ½À´Ï´Ù.

¸»ÃÊÇ÷°ü ±â±âÀÇ ÁÖ¿ä ¿ëµµ´Â?

¸»ÃÊÇ÷°ü ±â±â´Â ´Ù¾çÇÑ ÀÇ·á ºÐ¾ß¿¡ ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ÁßÀçÀû ½ÉÀåÇп¡¼­ ÀÌ·¯ÇÑ ±â±â´Â PAD Ä¡·á¿¡ »ç¿ëµÇ¸ç, PAD´Â ¸»ÃÊ µ¿¸Æ, ÀϹÝÀûÀ¸·Î ´Ù¸®ÀÇ µ¿¸ÆÀÌ Á¼¾ÆÁ® ÅëÁõ°ú À̵¿ ¹®Á¦¸¦ À¯¹ßÇÏ´Â °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù. dz¼±À̳ª ½ºÅÙÆ®¸¦ ÀÌ¿ëÇÑ Ç÷°ü ³» Ä¡·á´Â ÀÌ·¯ÇÑ µ¿¸ÆÀ» ÀçÅë°ú½ÃÄÑ Ç÷·ù¸¦ ȸº¹½ÃÄÑ Áõ»óÀ» ¿ÏÈ­ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. Ç÷°ü¿Ü°ú¿¡¼­´Â µ¿¸Æ·ù Ä¡·á¿¡ ÀÖ¾î ÀÌ½ÄÆíÀ̳ª Ç÷°ü ³» µ¿¸Æ·ù Ä¡·á(EVAR) ½Ã½ºÅÛ°ú °°Àº ±â±¸°¡ ÇʼöÀûÀÔ´Ï´Ù. µ¿¸Æ·ù´Â Ç÷°üº®ÀÌ ºÎÇ®¾î ¿À¸£°Å³ª ¾àÇØÁø ºÎºÐÀ¸·Î, Á¦´ë·Î °ü¸®ÇÏÁö ¾ÊÀ¸¸é ÆÄ¿­µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸»ÃÊÇ÷°ü ±â±â´Â DVT¿Í °°Àº Á¤¸Æ Áúȯ °ü¸®¿¡ ÇʼöÀûÀ̸ç, Ç÷Àü Á¦°Å ÀåÄ¡¿Í ÇÊÅÍ´Â Æó»öÀüÁõ°ú °°Àº »ý¸íÀ» À§ÇùÇÏ´Â ÇÕº´ÁõÀ» ¿¹¹æÇÕ´Ï´Ù. ´Ù¾çÇÑ Ç÷°ü Áúȯ¿¡ ´ëÀÀÇÏ´Â ÀÌµé ±â±âÀÇ ´Ù¾ç¼º°ú À¯È¿¼ºÀº Çö´ë ÀÇ·á ÇöÀå¿¡¼­ ±× Á߿伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

¸»ÃÊÇ÷°ü ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¸»ÃÊÇ÷°ü ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Áß¿äÇÑ ÃËÁø¿äÀÎ Áß Çϳª´Â ½ÉÇ÷°ü Áúȯ ¹× ¸»ÃÊÇ÷°ü ÁúȯÀÇ À§ÇèÀ» Áõ°¡½ÃŰ´Â ´ç´¢º´, °íÇ÷¾Ð°ú °°Àº »ýȰ½À°üº´ÀÇ À¯º´·ü Áõ°¡ÀÔ´Ï´Ù. ¶ÇÇÑ, Ç÷°ü ÀåÄ¡ÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» Çâ»ó½ÃŰ´Â ±â¼úÀÇ ¹ßÀüÀº Ä¡·á °¡´ÉÇÑ ÁúȯÀÇ ¹üÀ§¸¦ ³ÐÈ÷°í ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ¿© ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °í·ÉÀÚ´Â Ç÷°ü Áúȯ¿¡ °É¸®±â ½±±â ¶§¹®¿¡ Àü ¼¼°è Àα¸ÀÇ °í·ÉÈ­°¡ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ±âÁ¸ ¼ö¼ú¿¡ ºñÇØ ȸº¹ ½Ã°£ÀÌ Âª°í ÇÕº´ÁõÀÌ ÀûÀº ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ ÀåºñÀÇ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï ½ÃÀåÀÇ ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼º Çâ»óÀ¸·Î »õ·Î¿î ¼ºÀå ±âȸ°¡ âÃâµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ¸»ÃÊÇ÷°ü ±â±â ½ÃÀåÀº Çõ½ÅÀûÀ̰í È¿°úÀûÀÎ Ç÷°ü Ä¡·á¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä¿¡ ÈûÀÔ¾î °ßÁ¶ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

ºÎ¹®

µð¹ÙÀ̽º À¯Çü(Ç÷°ü¼ºÇü¼ú¿ë ½ºÅÙÆ®, Ç÷°ü¼ºÇü¼ú¿ë dz¼±, EVAR ½ºÅÙÆ® ±×·¡ÇÁÆ®, Ä«Å×ÅÍ, ÇöóÅ© ¼öÁ¤ µð¹ÙÀ̽º, Ç÷Çà µ¿Å º¯°æ µð¹ÙÀ̽º, ÇÏ´ëÁ¤¸Æ ÇÊÅÍ, ±âŸ µð¹ÙÀ̽º À¯Çü)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Peripheral Vascular Devices Market to Reach US$16.0 Billion by 2030

The global market for Peripheral Vascular Devices estimated at US$12.7 Billion in the year 2024, is expected to reach US$16.0 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Angioplasty Stents, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$9.1 Billion by the end of the analysis period. Growth in the Angioplasty Balloon segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.4 Billion While China is Forecast to Grow at 3.6% CAGR

The Peripheral Vascular Devices market in the U.S. is estimated at US$3.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 3.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Peripheral Vascular Devices Market - Key Trends and Drivers Summarized

Why Are Peripheral Vascular Devices Essential in Modern Medicine?

Peripheral vascular devices are critical tools in the diagnosis and treatment of diseases affecting the peripheral blood vessels, including arteries, veins, and lymphatic vessels outside of the heart and brain. These devices, which include stents, catheters, balloons, and filters, are used to manage conditions such as peripheral artery disease (PAD), deep vein thrombosis (DVT), and chronic venous insufficiency (CVI). The importance of these devices lies in their ability to restore proper blood flow, reduce the risk of complications, and improve patient outcomes. For instance, angioplasty balloons and stents are utilized to open narrowed or blocked arteries, enhancing blood circulation and preventing tissue damage. The development of minimally invasive techniques involving these devices has revolutionized vascular surgery, reducing recovery times and improving the quality of life for patients.

How Are Technological Advancements Shaping Peripheral Vascular Devices?

Technological advancements are significantly enhancing the functionality and efficacy of peripheral vascular devices. Innovations such as drug-eluting stents, which release medication to prevent restenosis, and bioresorbable stents, which gradually dissolve after restoring blood flow, represent significant breakthroughs in vascular treatment. Additionally, advancements in imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are improving the precision of device placement and the assessment of vascular conditions. The integration of advanced materials, like shape-memory alloys and biocompatible polymers, is enhancing the durability and performance of these devices. Furthermore, the development of hybrid devices that combine multiple functions, such as drug delivery and mechanical support, is expanding the therapeutic options available to clinicians. These technological strides are making treatments safer, more effective, and less invasive.

What Are the Key Applications of Peripheral Vascular Devices?

Peripheral vascular devices have a wide range of applications across various medical disciplines. In interventional cardiology, these devices are used to treat PAD, which is characterized by the narrowing of peripheral arteries, typically in the legs, leading to pain and mobility issues. Endovascular treatments using balloons and stents help to reopen these arteries, restoring blood flow and alleviating symptoms. In vascular surgery, devices like grafts and endovascular aneurysm repair (EVAR) systems are essential for treating aneurysms, which are bulging or weakened areas in the vessel walls that can rupture if not managed properly. Additionally, peripheral vascular devices are crucial in managing venous diseases, such as DVT, where clot removal devices and filters prevent life-threatening complications like pulmonary embolism. The versatility and effectiveness of these devices in addressing various vascular conditions highlight their importance in contemporary medical practice.

What Factors Are Driving the Growth in the Peripheral Vascular Devices Market?

The growth in the peripheral vascular devices market is driven by several factors. One significant driver is the increasing prevalence of cardiovascular diseases and lifestyle-related conditions such as diabetes and hypertension, which heighten the risk of peripheral vascular disorders. Technological advancements that enhance the safety and efficacy of vascular devices are also propelling market growth, as they expand the range of treatable conditions and improve patient outcomes. Additionally, the aging global population is contributing to market expansion, as older adults are more susceptible to vascular diseases. The rising demand for minimally invasive procedures, which offer shorter recovery times and fewer complications compared to traditional surgeries, is further boosting the adoption of these devices. Moreover, increasing healthcare expenditure and improved access to advanced medical technologies in emerging markets are creating new opportunities for growth. These factors collectively ensure a robust growth trajectory for the peripheral vascular devices market, driven by the ongoing need for innovative and effective vascular treatments.

SCOPE OF STUDY:

The report analyzes the Peripheral Vascular Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device Type (Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters, Other Device Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 38 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â